Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia
Open Access
- 1 January 2012
- journal article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 3, 195
- https://doi.org/10.3389/fphar.2012.00195
Abstract
The Dopamine Hypothesis of Schizophrenia is actively being challenged by the NMDA Receptor Hypofunctioning Hypothesis of Schizophrenia. The latter hypothesis may actually be the starting point in neuronal pathways that ultimately modifies dopamine pathways involved in generating both positive and negative symptoms of schizophrenia postulated by the former hypothesis. The authors suggest that even this latter, NMDA receptor-based, hypothesis is likely too narrow and offer a review of typical glutamate and dopamine-based neurocircuitry, propose genetic vulnerabilities impacting glutamate neurocircuitry, and a provide a broad interpretation of a possible etiology of schizophrenia. In conclusion, there is a brief review of potential schizophrenia treatments that rely on the etiologic theory provided in the body of the paper.Keywords
This publication has 48 references indexed in Scilit:
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV SchizophreniaJournal of Clinical Psychopharmacology, 2011
- Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term PlasticityFrontiers in Psychiatry, 2011
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophreniaInternational Journal of Neuropsychopharmacology, 2009
- Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophreniaGenes, Brain and Behavior, 2009
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Acute Effects of the Ampakine Farampator on Memory and Information Processing in Healthy Elderly VolunteersNeuropsychopharmacology, 2006
- Regulator of G‐protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density familiesNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2004
- Confirming RGS4 as a susceptibility gene for schizophreniaNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2003
- Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptorMolecular Psychiatry, 2002
- The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophreniaMolecular Psychiatry, 2001